Abstract:
The present invention provides a foamed and/or aerated substrate for transmucosal and/or transdermal applications. The foamed and/or aerated substrate may be in the form of a film, sheet, strip or wafer. The foamed and/or aerated substrate is suitable for use in applications such as, for example, adhesive denture liners, tooth whitening, and smoking control/cessation. The foamed and/or aerated substrate is polymeric in nature and comprises one or more polymers and one or more foaming agents. Additionally, the foamed and/or aerated substrate may include, but not limited to, one or more plasticizers, hydrophobic barrier agents, tooth whitening agents, antioxidants, preservatives, super-disintegrants or absorbents, flavorants, deodorants, breath freshening agents, colorants, surfactants, film modifiers, cross-linking agents, antimicrobial agents, control release agents, other therapeutic agents, or any combinations thereof.
Abstract:
The invention relates to a method for modifying cellulose ethers. The inventive method is characterised in that a cellulose ether having a humidity content of between 5 and 90% is intensively mixed with between 0.1 and 5 wt. %—in relation to the dry cellulose ether—of an additive or an additive mixture in the form of an aqueous or organic suspension or solution, at temperatures of between 20 and 100° C., and the mixture obtained is then dried.
Abstract:
The present invention relates to an articulating aid for use in dentistry, which is characterised in that it has, on at least one side of a support layer, a plurality of differently coloured colour layers comprising colouring pigments and at least one adhesion promoter for at least one colouring pigment of at least one of the coloured colour layers
Abstract:
Bone graft substitute compositions and methods of making the compositions are disclosed. In some embodiments, a method of making a composition includes contacting a mixing solution with a first mixture having calcium sulfate hemihydrate and a plasticizing material to form a second mixture; waiting a predetermined period of time after forming said second mixture; and then contacting demineralized bone with the second mixture to form the composition. A composition can be formed from a kit including a first mixture having calcium sulfate hemihydrate and a plasticizing substance, a second mixture having demineralized bone, and a mixing solution. The first and second mixtures and the mixing solution are unblended.
Abstract:
The present invention provides a coprecipitate of 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H), 10-dio xo-2H-1,2,3-triazolo[4,5-c][1]benzazepine and a water-soluble polymer, excellent in solubility and absorbability.
Abstract:
This invention relates to biopolymer-based compositions and biopolymer-based formed bodies such as film, sheet, capsule, casing or coating-film or spray thereof. In another embodiment, the invention relates to a process for producing a biopolymer-based starting material and biopolymer-based formed bodies such as cited above, for the manufacture of pharmaceutical, veterinary, food for cosmetic products.
Abstract:
A resin composition, which comprises a biodegradable polymer and a biodegradable liquid crystalline polymer. The resin composition is useful for producing molded resin articles having good recyclability.
Abstract:
A paper treating agent comprising 100 parts by mass of organopolysiloxane (A), from 100 to 100,000 parts by mass of water (E), and 0.1 to 100 parts by mass of a surfactant (F), characterized in that the agent further comprises 50 to 1,000 parts by mass of a cellulosic resin (C), wherein 0.5 to 2.5 hydroxyl groups per glucose unit of said cellulosic resin are etherized or esterified, and a viscosity of an aqueous 2% solution of said cellulosic resin is from 2 to 100 mpa.s.
Abstract:
A peroxide product is provided. The peroxide product includes a package having a headspace, a substrate disposed within the package, and a thin layer of a composition having a peroxide active and a polyol, wherein the thin layer is disposed adjacent the substrate. The peroxide product also includes at least one means for increasing the stability of the peroxide active of the composition. The thin layer of the composition has at least about 43% of its original concentration of the peroxide active at twelve months after manufacture when stored at about 25° C. and in the absence of light.